In each experiment, PERL treatment was more effective than lovastatin and therefore may be better suited for
in vivo antiviral therapy. Furthermore, the potential use of PERLs for
in vivo treatment of viral infections, as well as the frequent coinfections with the viruses tested here, eventually should include the encapsulation of other antiviral therapies, leading to enhanced treatment efficacy.